HCW Biologics Alternatives & Competitors

12 companies similar to HCW Biologics — We are creating transformative immunotherapies to lengthen healthspan by disrupt...

Inflammx Therapeutics, Inc.

Modulation of Inflammasome mediated Autoinflammation - in Ophthalmology, Nephropathy and...

3 Venture round $78.59M

Tampa, United States

Biotechnology Health Care +2

Paratus Sciences

Translating evolutionary insights into first-in-class medicines

19 Series A $100.00M

Boston, United States

Biotechnology Health Care

Greywolf Therapeutics

We are advancing novel antigen modulation technology that controls T cells to guide the im...

49 Series B $107.10M

United Kingdom

Biotechnology Health Care +1

NodThera

Treating chronic disease by targeting inflammation at its source

22 Series B $77.08M

Philadelphia, United Stat...

Biotechnology Health Care +1

Rival Readout

Competing with HCW Biologics? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

Nuvig Therapeutics Inc.

Rebalancing Immune Function for Chronic Inflammatory and Autoimmune Diseases

24 Series A $47.00M

Menlo Park, United States

Biotechnology Health Care +1

Immunaeon

Connecting Today's Science to Tomorrow's Cures

5 $480.00K

Buffalo, United States

Biopharma Biotechnology +2

AnaptysBio

Transforming patient health by delivering innovative immunology therapeutics.

144 IPO $185.90M

San Diego, United States

Biotechnology Health Care +1

Azome Therapeutics

Developing selective NLRP3 inflammasome inhibitors for severe inflammatory diseases

3 Seed

Biopharma Biotechnology +1

Inflazome

Inflazome develops drugs to block inflammasome signals, reducing unwanted inflammation ass...

2-10 Grant $58.00M

Biopharma Biotechnology +1

Celergen Inc.

Using nature's most powerful ingredients, Celergen helps the body heal itself and combat s...

Austin, United States

Biotechnology Health Care

Upstream Bio

Developing treatments for inflammatory diseases

78 IPO $693.00M

Waltham, United States

Biotechnology Health Care +2

Edifice Health, Inc.

Early Detection of Systemic Chronic Inflammation to Improve Immune Health and Healthy Agin...

5 Series A $13.50M

San Mateo, United States

Biotechnology Health Care +1

About HCW Biologics

HCW Biologics is a biotechnology startup founded in 2018 and headquartered in the United States. The company's slogan "We are creating transformative immunotherapies to lengthen healthspan by disrupting inflamm-aging" encapsulates its focus on developing proprietary immunotherapy candidates to address chronic inflammat...

Business keywords

Immunotherapy, Healthspan, Inflamm-aging, Immunology, Chronic Inflammation, Inflammasome Modulation, Senescent Cell Clearance

Frequently Asked Questions

Companies similar to HCW Biologics include Inflammx Therapeutics, Inc., Paratus Sciences, Greywolf Therapeutics, NodThera, Nuvig Therapeutics Inc.. They work in Biotechnology and Health Care and share HCW Biologics's focus on immunotherapy, immunology and chronic inflammation.

Bounce Watch lists 12 companies that share HCW Biologics's industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around HCW Biologics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

HCW Biologics Profile Inflammx Therapeutics, Inc. Alternatives Paratus Sciences Alternatives Greywolf Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at HCW Biologics on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.